<p>All analyses restricted to patients that transferred out with at least 1 year of follow-up on ART at this service. This was done to allow sufficient time for virological suppression as well as for blood samples to be drawn at most 3 times for CD and VL measurements.</p>*<p>CD4 cell count data at the time of transfer were available for 329 ART naïve and 45 ART non naïve patients.</p>†<p>Viral load data at the time of transfer were available for 329 ART naïve and 45 ART non-naïve patients.</p
†<p>Models adjusted for sex, baseline CD4 count, age, treatment site, tuberculosis at ART initiation...
The treatment outcomes for large-scale public antiretroviral therapy (ART) programs in developing co...
*<p>Among patients with at least 1 viral load between 1 month and 1 year after ART initiation.</p>+<...
To determine the proportion, characteristics and outcomes of patients who transfer-out from an antir...
To determine the proportion, characteristics and outcomes of patients who transfer-out from an antir...
Objectives: To determine the proportion, characteristics and outcomes of patients who transfer-out f...
<p>Retention by CD4 count at first viral load (retained in care on December 31, 2012) at the nationa...
*<p>Closest up to 24 weeks before ART stop. NB: 2 chronically-infected participants had CD4 count <3...
Antiretroviral therapy (ART) has been scaled-up rapidly in Africa. Programme reports typically focus...
Antiretroviral therapy (ART) has been scaled-up rapidly in Africa. Programme reports typically focus...
<p>A) median CD4+ cell count (cells/mm<sup>3</sup>) over time on ART; and, B) percentage of patients...
Demographic and clinical characteristics of HIV-infected patients on ART with high viral load (≥1000...
Demographic & clinical characteristics associated with suppression of viral load on repeat testing i...
<p>*Tertiary institutions includes Technical/Vocational and University.</p><p>**Baseline CD4 T-cell ...
Demographic & clinical characteristics associated with suppression of viral load in those who underw...
†<p>Models adjusted for sex, baseline CD4 count, age, treatment site, tuberculosis at ART initiation...
The treatment outcomes for large-scale public antiretroviral therapy (ART) programs in developing co...
*<p>Among patients with at least 1 viral load between 1 month and 1 year after ART initiation.</p>+<...
To determine the proportion, characteristics and outcomes of patients who transfer-out from an antir...
To determine the proportion, characteristics and outcomes of patients who transfer-out from an antir...
Objectives: To determine the proportion, characteristics and outcomes of patients who transfer-out f...
<p>Retention by CD4 count at first viral load (retained in care on December 31, 2012) at the nationa...
*<p>Closest up to 24 weeks before ART stop. NB: 2 chronically-infected participants had CD4 count <3...
Antiretroviral therapy (ART) has been scaled-up rapidly in Africa. Programme reports typically focus...
Antiretroviral therapy (ART) has been scaled-up rapidly in Africa. Programme reports typically focus...
<p>A) median CD4+ cell count (cells/mm<sup>3</sup>) over time on ART; and, B) percentage of patients...
Demographic and clinical characteristics of HIV-infected patients on ART with high viral load (≥1000...
Demographic & clinical characteristics associated with suppression of viral load on repeat testing i...
<p>*Tertiary institutions includes Technical/Vocational and University.</p><p>**Baseline CD4 T-cell ...
Demographic & clinical characteristics associated with suppression of viral load in those who underw...
†<p>Models adjusted for sex, baseline CD4 count, age, treatment site, tuberculosis at ART initiation...
The treatment outcomes for large-scale public antiretroviral therapy (ART) programs in developing co...
*<p>Among patients with at least 1 viral load between 1 month and 1 year after ART initiation.</p>+<...